Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
The asset manager announced annual revenues rose 14%, topping $20 billion for the first time, with record net inflows of $641 billion.
It’s basic Newtonian physics, as Boeing just learned: When the sky falls for a company, so, too, will the bottom line.
The company’s struggle gives us a glimpse into how the wider world of voice assistants is trying to keep up with the technology zeitgest.